The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Verzhanskaia T.Iu.

FGBU "Moskovskiĭ NII glaznykh bolezneĭ im. Gel'mgol'tsa" Minzdrava Rossii

Atropine use for progressive myopia in children and adolescents

Authors:

Verzhanskaia T.Iu.

More about the authors

Journal: Russian Annals of Ophthalmology. 2017;133(3): 89‑98

DOI: 10.17116/oftalma2017133389-98

Read: 65348 times

Download PDF (RU)
Contact the author
Table of contents

ATROPINE USE FOR PROGRESSIVE MYOPIA IN CHILDREN AND ADOLESCENTS
ATROPINE USE FOR PROGRESSIVE MYOPIA IN CHILDREN AND ADOLESCENTS

To cite this article:

Verzhanskaia TIu. Atropine use for progressive myopia in children and adolescents. Russian Annals of Ophthalmology. 2017;133(3):89‑98. (In Russ.)
https://doi.org/10.17116/oftalma2017133389-98

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Correction of myopia with implantable collamer lenses. Russian Annals of Ophthalmology. 2025;(2):5-15
Microbiota of the ocular surface in children with myopia. Russian Annals of Ophthalmology. 2025;(3):5-12
Clinical expe­rience with 0.01% atro­pine for myopia control in children in Azerbaijan. Russian Annals of Ophthalmology. 2025;(4):29-33
Indi­cators of computer acco­mmodography as predictors of the deve­lopment of myopic refraction. Russian Annals of Ophthalmology. 2025;(4):41-48
Dete­rmining the age of myopia onset in schoolchildren based on medi­cal examination data. Russian Annals of Ophthalmology. 2025;(5):46-52
Resu­lts of corneal confocal microscopy in cavi­tation-related complications of femtosecond LASIK. Russian Annals of Ophthalmology. 2025;(6):63-68
Prognostic role of early changes in choroidal thickness during opti­cal therapy with HAL lenses in children with progressive myopia. Russian Annals of Ophthalmology. 2025;(6):69-74
Biomechanical properties of the corneal stroma extracted during the SMILE surgery in myopia with varying axial length. Russian Annals of Ophthalmology. 2025;(6):135-144
Inve­stigation of the biomechanical properties of corneal lenticules in myopia and myopic asti­gmatism after femtosecond laser vision correction with the CLEAR technique. Russian Annals of Ophthalmology. 2025;(6):145-152
Asse­ssment of the rela­tionship between the use of digi­tal devi­ces and the transformation of the daily routine of schoolchildren. Russian Journal of Preventive Medi­cine. 2025;(6):74-80
Abstract:

The worldwide prevalence of myopia varies within the range of 20—50% among the adult population of Europe and the United States reaching 60—90% in Asian countries. Reduction of pediatric myopia rates is an important task of medicine. From many reported conservative methods for stabilization of myopia, those that involve pharmaceutical measures are worth paying attention to. This review covers publications dated 1964 or later that contain the results of atropine use at different concentrations in children and adolescents with a minimum follow-up period of 5 years. Atropine mechanisms of action and side effects at different concentrations of the drug are also analyzed. The authors point out potential health hazards for patients on atropine therapy. The principal conclusion: low-dose atropine (0.01%) makes a good compromise between potential negative effects and statistically significant slowing of myopia progression proved in numerous studies. It is recommended that children at the age of 8—13 years undergo at least a 2-year course of atropine therapy.

Keywords:

myopia
atropine
slowing of progressive myopia
axial eye length
children and adolescents
annual gradient of progression

Authors:

Verzhanskaia T.Iu.

FGBU "Moskovskiĭ NII glaznykh bolezneĭ im. Gel'mgol'tsa" Minzdrava Rossii

Close metadata

References:

  1. Cooper J, Schulman E, Jamal N. Current status on the development and treatment of myopia. Optometry. 2012;83(5):179-199.
  2. Takahiro Hiraoka, Tetsuhiko Kakita, Fumiki Okamoto et al. Long-Term Effect of Overnight Orthokeratology on Axial Length Elongation in Childhood Myopia: A 5-Year Follow-Up Study. Investigative Ophthalmology & Visual Science. 2012;53(7):3913-3919.
  3. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042. https://doi.org/10.1016/j.ophtha.2016.01.006
  4. Pararajasegaram R. VISION 2020 — the right to sight: from strategies to action. Am J Ophthalmol. 1999;128:359-360.
  5. Chew SJ et. al., Muscarinic antagonists for myopia control. Myopia updates. The 6th International Conference on Myopia, Tokio. 1998.
  6. Luft WA, Ming Y, Stell WK. Variable effects of previously untested muscarinic receptor antagonists on experimental myopia. Invest Ophthalmol Vis Sci. 2003;44(3):1330-1338.
  7. Smith EL, 3rd, Huang J, Hung LF, Blasdel TL, Humbird TL, Blockhorst KH. Hemiretinal form deprivation: evidence for local control of eye growth and refractive development in infant monkeys. Invest Ophthalmol Vis Sci. 2009;50(11):5057-5069.
  8. Kennedy RH, Dyer JA, Kennedy MA, Parulkar S, Kurland LT, Herman DC et al. Reducing the progression of myopia with atropine: a long term cohort study of Olmsted County students. Binocul Vis Strabismus Q. 2000;15(3,Suppl):281-304.
  9. Bedrossian RH. Rview of the Deevelopment and Treatment of Myopia — Cooper Eye Care. Ann Ophthalmol. 1989;21(5):180-182,187.
  10. Bedrossian RH. The effect of atropine on myopia. Ann Ophthalmol. 1971;3(8):891-897.
  11. Bedrossian RH. The effect of atropine on myopia. Ophthalmology. 1979;86(5):713-719.
  12. Gimbel HV. The control of myopia with atropine. Can J Ophthalmol. 1973;8(4):527-532.
  13. Kelly TS, Chatfield C, Tustin G. Clinical assessment of the arrest of myopia. Br J Ophthalmol. 1975;59(10):529-538.
  14. Dyer JA. Role of cyclopegics in progressive myopia. Ophthalmology. 1979;86(5):692-694.
  15. Sampson WG. Role of cycloplegia in the management of functional myopia. Ophthalmology. 1979;86(5):695-697.
  16. Bedrossian RH. The treatment of myopia with atropine and bifocals: a long-term prospective study. Ophthalmology. 1985;92(5):716.
  17. Gruber E. Treatment of myopia with atropine and bifocals. Ophthalmology. 1985;92(7):985.
  18. Brodstein RS, Brodstein DE, Olson RJ, Hunt SC, Williams RR. The treatment of myopia with atropine and bifocals. A long-term prospective study. Ophthalmology. 1984;91(11):1373-1379.
  19. Brenner RL. Further observations on use of atropine in the treatment of myopia. Ann Ophthalmol. 1985;17(2):137-140.
  20. Yen MY, Liu JH, Kao SC, Shiao CH. Comparison of the effect of atropine and cyclopentolate on myopia. Ann Ophthalmol. 1989;21(5):180-182,187.
  21. Shih YF, Chen CH, Chou AC, Ho TC, Lin LL, Hung PT. Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther. 1999;15(1):85-90.
  22. Kennedy RH, Dyer JA, Kennedy MA, Parulkar S, Kurland LT, Herman DC, McIntire D, Jacobs D, Luepker RV. Reducing the progression of myopia with atropine: a long term cohort study of Olmsted County students. Binocul Vis Strabismus Q. 2000;15(3,Suppl):281-304.
  23. Chiang MF, Kouzis A, Pointer RW, Repka MX. Treatment of childhood myopia with atropine eyedrops and bifocal spectacles. Binocul Vis Strabismus Q. 2001;21(3):209-216.
  24. Shih YF, Hsiao CK, Chen CJ, Chang CW, Hung PT, Lin LL. An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression. Acta Ophthalmol Scand. 2001;79(3):233-236.
  25. Chua WH, Balakrishnan V, Chan YH, Tong L, Ling Y, Quah BL, et al. Atropine for the treatment of childhood myopia. Ophthalmology. 2006;113(12):2285-2291.
  26. Lee JJ, Fang PC, Yang IH, Chen CH, Lin PW, Lin SA, Kuo HK, Wu PC. Prevention of myopia progression with 0.05% atropine solution. J Ocul Pharmacol Ther. 2006;22(1):41-46.
  27. Lu PC, Chen JC. Retarding progression of myopia with seasonal modification of topical atropine. J Ophthalmic Vis Res. 2010;5(2):75-81.
  28. Fang PC, Chung MY, Yu HJ, Wu PC. Prevention of myopia onset with 0.025% atropine in premyopic children. J Ocul Pharmacol Ther. 2010;26(4): 341-345. https://doi.org/10.1089/jop.2009.0135
  29. Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, et. al. Atropine for the treatment of childhood myopia: safety and efficacy of 0,5%, 0,1%, and 0,01% Doses (ATOM2). Ophthalmology. 2012;119; 347-354.
  30. Chia A, Lu QS, Tan D. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. Ophthalmology. 2016;123(2):391-399. https://doi.org/10.1016/j.ophtha.2015.07.004
  31. Polling JR, Kok RG, Tideman JW, Meskat B, Klaver CC. Effectiveness study of atropine for progressive myopia in Europeans. Eye (Lond). 2016;30:998-1004.
  32. Tong L, Huang XL, Koh AL, Zhang X, Tan DT, Chua WH. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Ophthalmology. 2009;116(3):572-579. https://doi.org/10.1016/j.ophtha.2008.10.020
  33. Luu CD, Lau AM, Koh AH, Tan D. Multifocal electroretinogram in children on atropine treatment for myopia. Br J Ophthalmol. 2005;89(2):151-153.
  34. Wu TE, Yang CC, Chen HS. Does atropine use increase intraocular pressure in myopic children? Optom Vis Sci. 2012;89(2):E161-E167.
  35. Inzelberg R, Shapira T, Korczyn A. Effects of atropine on learning and memory functions in dementia. Clin Neuropharmacol. 1990;13(3):241-247.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.